Nature Paper from PACT Pharma and UCLA Highlights How Patients with Cancer Respond Differently to Anti-PD-1 Therapy
/PRNewswire/ -- PACT Pharma, Inc., a privately held biopharmaceutical company developing transformational personalized neoantigen-specific and off-the-shelf T...
United States Los Angeles Susan Whitehead Stefanie Mandl University Of California Impact Isolation Technology
Source: prnewswire.com